TITLE

Asthma that is unresponsive to usual care

AUTHOR(S)
Chapman, Kenneth R.; McIvor, Andrew
PUB. DATE
January 2010
SOURCE
CMAJ: Canadian Medical Association Journal;1/12/2010, Vol. 182 Issue 1, p45
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the management of severe asthma. It is stated that the management of severe asthma is a complex process and it is crucial to confirm the diagnosis. It is stated that therapy in severe asthma must be tailored to the individual patient and monitored regularly. It also presents a case of 38 year old woman suffering from asthma. It informs about several therapies for uncontrolled asthma and concludes that omalizumab therapy is safe for patients with severe asthma.
ACCESSION #
47771286

 

Related Articles

  • The ebb and flow of asthma. Toelle, B. G.; Marks, G. B. // Thorax;Feb2005, Vol. 60 Issue 2, p87 

    The article attempts to find reasons for the decrease in the prevalence of asthma at the outset of the 21st century. During the 1980s and early 1990s several repeat cross sectional studies, conducted in widely varying regions of the world, reported an increase in the prevalence of symptoms of...

  • Interferon might halt asthma. Liddle, Rachel // GP: General Practitioner;8/18/2006, p2 

    The article reports on the findings of the researchers in Great Britain, who revealed that exacerbations can be treated and prevented with antiviral protein interferon-lambda. The inhaler used by asthmatics deliver the protein to the lungs. A lung biopsy conducted on the asthmatics revealed low...

  • Treatment Comparison of Budesonide/ Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged ≥16 Years with Asthma: Post Hoc Analysis of a Randomized, Double-Blind Study. Kuna, Piotr // Clinical Drug Investigation;2010, Vol. 30 Issue 9, p565 

    Background: Three fixed maintenance-dose inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) combinations for the treatment of asthma are currently available: salmeterol/fluticasone propionate (Seretide™/Advair™/ Adoair™) budesonide/formoterol (Symbicort®) and...

  • Measuring asthma control in general practice. Gruffyd-Jones, Kevin // Pulse;7/26/2004, Vol. 64 Issue 30, p37 

    Reports on the improvement of process of care for asthmatic patients in general practice. Ways in monitoring asthma control; Outcome measures for disease control monitoring; Guidelines in identifying severity of disease and providing routine care.

  • Choosing Asthma Step-up Care. von Mutius, Erika; Drazen, Jeffrey M. // New England Journal of Medicine;3/18/2010, Vol. 362 Issue 11, p1042 

    The authors discuss how to choose the right step-up care for asthma, which is considered as an easy and hard medical condition to treat. They say that asthma is easy to treat because it requires little medication while it becomes hard when control is not obtained with the first choice of a...

  • Assessment of Asthma Control in a Sample of Asthmatic Patients in Taif City, Saudi Arabia. El Margoushy, Nesriene; Alkhald, Sahar Musarri; Al Khaldi, Nawal Zewaid; El Nashar, Nihad // Egyptian Journal of Hospital Medicine;Jan2016, Vol. 62, p1 

    Background: asthma Control Test (ACT) Questionnaire is developed to meet the guidelines internationally accepted for asthma management by measuring adequacy and any alteration in control of asthma, occurring spontaneously or after starting asthma management. Objectives: to assess control of...

  • How asthma care is changing. Hall, Julie // Independent Nurse;8/4/2008, p27 

    The article features the recent innovations for the treatment of asthma in Great Britain. One of the recently made innovations includes the chloroflurocarbon (CFC)-containing preventers which require half-dose reduction due to particle size and are available as a breath-actuated product....

  • Does Mild Persistent Asthma Require Regular Treatment? Fabbri, Leonardo M. // New England Journal of Medicine;4/14/2005, Vol. 352 Issue 15, p1589 

    Discusses the treatment of mild persistent asthma. Claim that established guidelines require regular treatment of mild persistent asthma with inhaled corticosteroids; Reference to a study which compared treatment methods; Focus of the study on self-management of mild persistent asthma; Benefits...

  • YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment. Tianwen Lai; Min Chen; Zaichun Deng; Yingying L¿; Dong Wu; Dongming Li; Bin Wu // BMC Pulmonary Medicine;2015, Vol. 15 Issue 1, p1 

    Background YKL-40 is also called chitinase-3-like-1 (CHI3L1) protein and may be a marker for asthma. The aims of the present study were to investigate whether serum YKL-40 levels are stable or decreased in patients with asthma after appropriate treatment and to evaluate the correlation of YKL-40...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics